| dc.contributor.advisor | Ellekjær, Hanne | |
| dc.contributor.advisor | Spigset, Olav | |
| dc.contributor.advisor | Røsstad, Tove | |
| dc.contributor.advisor | Næss, Halvor | |
| dc.contributor.author | Gynnild, Mari Nordbø | |
| dc.date.accessioned | 2022-03-24T07:05:04Z | |
| dc.date.available | 2022-03-24T07:05:04Z | |
| dc.date.issued | 2022 | |
| dc.identifier.isbn | 978-82-326-5181-8 | |
| dc.identifier.issn | 2703-8084 | |
| dc.identifier.uri | https://hdl.handle.net/11250/2987183 | |
| dc.language.iso | eng | en_US |
| dc.publisher | NTNU | en_US |
| dc.relation.ispartofseries | Doctoral theses at NTNU;2022:87 | |
| dc.relation.haspart | Paper 1:
Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege; Munthe-Kaas, Ragnhild; Knapskog, Anne Brita; Lydersen, Stian; Næss, Halvor; Røsstad, Tove Garåsen; Seljeseth, Yngve Müller; Thingstad, Pernille; Saltvedt, Ingvild; Ellekjær, Hanne.
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine 2020 s. 1-14
https://doi.org/10.1111/joim.13161
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (CC BY-NC-ND 4.0) | |
| dc.relation.haspart | Paper 2:
Gynnild, Mari Nordbø; Hageman, Steven HJ; Dorresteijn, Jannick AN; Spigset, Olav; Lydersen, Stian; Wethal, Torgeir; Saltvedt, Ingvild; Visseren, Frank LJ; Ellekjær, Hanne.
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology 2021 ;Volum 13. s. 813-823
https://doi.org/10.2147/CLEP.S322779
This is an open access article under the terms of the Attribution-NonCommercial 3.0 Unported License (CC BY-NC 3.0) | |
| dc.relation.haspart | Paper 3:
Gynnild, Mari Nordbø; Hageman, Steven HJ; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN; Visseren, Frank LJ; Ellekjær, Hanne.
Prescription patterns for lipid-lowering therapy after ischemic stroke and expected benefit from intensification of treatment. | |
| dc.title | RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations | en_US |
| dc.type | Doctoral thesis | en_US |
| dc.subject.nsi | VDP::Medical disciplines: 700 | en_US |
| dc.description.localcode | Digital fulltext is not available | en_US |
